News

Anti-TNF agents such as AbbVie’s Humira (adalimumab) or Janssen’s Remicade (infliximab), were found to be effective in treating cutaneous sarcoidosis, according to a French study of 46 cases. The study, “Efficacy and Tolerance of Anti–Tumor Necrosis Factor α Agents in Cutaneous Sarcoidosis, A French Study…

Sarcoidosis may appear in cancer patients who respond well to treatment with dendritic cell-based vaccines, according to a case series report from Germany. At the Friedrich-Alexander-University Erlangen-Nürnberg and the associated Erlangen University Hospital, researchers noted three patients with malignant melanoma who developed sarcoidosis after or during such treatment.

A rare case report of a woman with sarcoidosis in the liver and spleen, who developed signs of inflammatory bowel disease (IBD) during recovery, illustrates that sarcoidosis can occur in less than typical ways. The study by researchers at the University of Bari Aldo Moro in Italy, titled “A…

A recent case report supports the theory that inhibiting a molecular pathway called programmed cell death-1 (PD-1) may involve processes that lead to sarcoidosis in some cancer patients. The study, “Nivolumab-related cutaneous sarcoidosis in a patient with lung adenocarcinoma,” was published in the journal JAAD Case Reports. Sarcoidosis, as well…

Increased levels of a specific type of T-cell in some patients with melanoma might explain the connection between the cancer and sarcoidosis, researchers suggest in a study that explored melanoma patients treated with immunotherapy. The study, “Immunotherapy-induced sarcoidosis in patients with melanoma treated with PD-1 checkpoint inhibitors: Case series and…

The prevalence of sarcoidosis may be associated with the presence of high levels of certain chemical elements in the environment, a new study suggests. More studies are warranted to confirm the possible link to pollution. The study was published in the journal PLoS One in an article titled “Sarcoidosis in an…

Treatment with cibinetide (ARA 290) was shown to promote significant corneal nerve and improve pain and functional capacity in a clinical trial with sarcoidosis patients. The trial was conducted by Araim Pharmaceuticals. Results of the trial were published in the journal Investigative Ophthalmology & Visual Science, in an…

A single mother from the American Midwest with sarcoidosis has started a crowdfunding campaign on the GoFundMe platform to move to a warmer climate to improve her life. The campaign has been described as one of GoFundMe’s most important and life-changing of 2017. Stephanie Jordan of Calumet City, Illinois,…

Sarcoidosis patients are more susceptible to hospitalization than the general population, especially female patients, according to results of a new study. More studies are warranted to understand the reasons why women with sarcoidosis seem to be particularly disposed to hospitalization. The study, “Hospitalization Among Patients With Sarcoidosis: A Population-Based Cohort…

A case was recently reported of a 27-year-old woman who presented ocular pain and moderate vision impairment as the first symptoms of sarcoidosis. Clinicians from the University of Ottawa in Canada reported the case study in the Canadian Medical Association Journal. Sarcoidosis is an inflammatory chronic disease that can…